SCHEMBL7878084

SCHEMBL7878084

CNC(N)=NC(=O)c1cc2cccc(Oc3ccccc3)c2[nH]1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 4/20 0.39
RHEB Q15382 1/20 0.38
NSD2 O96028 1/20 0.38
MEN1 O00255 1/20 0.38
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
KMT2A Q03164 1/20 0.38
HSD17B10 Q99714 1/20 0.38
XDH P47989 2/20 0.38
CTNNB1 P35222 1/20 0.37
FLT3 P36888 2/20 0.37
HRH4 Q9H3N8 1/20 0.37
BRAF P15056 2/20 0.37
SLC9A1 P19634 1/20 0.35
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7884340 0.91 HRH4 (0.36) BRD4NSD2FLT3HRH4MTNR1A
SCHEMBL7881906 0.90 CARM1 (0.36) BRD4FLT3HRH4BRAFSLC9A1
SCHEMBL7881245 0.90 IDO1 (0.39) FLT3HRH4MTNR1AMTNR1B
Hydrochloric Acid SCHEMBL7880730 0.90 HRH4 (0.35) BRD4NSD2FLT3HRH4MTNR1A
SCHEMBL7873969 0.89 CARM1 (0.38) NSD2FLT3HRH4MTNR1AMTNR1B
SCHEMBL7873378 0.88 HDAC3 (0.40) BRD4NSD2MEN1USP2ALDH1A1
SCHEMBL7882052 0.88 PLAU (0.38) FLT3HRH4BRAFMTNR1AMTNR1B
SCHEMBL7879425 0.88 IDO1 (0.46) ALDH1A1
Hydrochloric Acid SCHEMBL7878081 0.87 HDAC3 (0.40) BRD4NSD2MEN1USP2ALDH1A1
SCHEMBL7885063 0.87 MEN1 (0.38) MEN1ALDH1A1KMT2AXDHGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed